Dean Glenn Hubbard explains five reforms to the U.S. health care system that may save as much as $60 billion a year while extending coverage and increasing consumer choice.
Professor Andrew Schmidt discusses the impact of Obama's proposed tax code changes. What industries will be affected?
Big Pharma companies are putting billions on the line into high-risk projects and need better support from the government.
Sidney Taurel '71, chairman of Eli Lilly & Co., spoke about how he would spend $10 billion to solve a world problem. How would you spend it?
Will the cost of overhauling the health care system take an undue toll on small businesses? Professor Rita McGrath says that could be the case.
A simple set of related rules can help doctors diagnose breast cancer using a less invasive type of biopsy.
At Columbia Business School's 5th Annual Healthcare Conference, industry leaders said they are looking for ways to drive innovation.
As growth slows in the pharmaceutical sector, shareholders are putting pressure on companies and their executives to make some difficult decisions.
Many of the propellants that have fueled national healthcare expenditures are deeply entrenched (“core”) aspects of either the healthcare system or our society’s values.
Can research from management science and marketing help explain - and possibly treat - depression and anxiety?
Why did Pfizer pursue this strategy? And will the acquisition encourage other Big Pharma players to take a similar approach?
Traditional supply chain models emphasize the benefits of consolidating production. But as Awi Federgruen explains, the recent flu vaccine crisis illustrates the risks of relying too heavily on a single supplier.
In the face of strenuous physical demands, many dancers smoke cigarettes — to the detriment of their health. Why do they do it? The answer may surprise you.
Jeff Kindler, chairman and CEO of Pfizer, spoke with students about the company's merger with Wyeth and its strategies for confronting market challenges. Read more about the discussion.
A mathematical model helps doctors offer every patient a same-day appointment.
A simple formula using available data shows how best to schedule patients for medical services involving costly equipment.
A queuing model for nurse staffing can cut costs and improve patient care.
New drugs and medical procedures account for much of the increase in the longevity of Americans — and haven’t increased the cost of care.
Nachum Sicherman, who has researched cost-benefit analysis in medical decision making, delves into the economic angles of the city’s controversial public health regulation.
Professor Frank Lichtenberg explains how expanded health insurance coverage is an economic value proposition.
Using smoking as a proxy for time preference may help explain why some workers invest more in career development than others.
"It's incredibly difficult to be a part-time entrepreneur. To do well, I believe you have to immerse yourself in your work. You have to go all in."
Findings on value creation and regulatory fit offer far-ranging implications for management, marketing and even mental health.
Cliff Cramer, who directs the School’s new Program in Healthcare and Pharmaceutical Management, explains how a multidisciplinary business education can help mend an increasingly convoluted and flawed industry.
An inventive method for reducing prescription noncompliance wins this year’s Outrageous Business Plan Competition.
Yesterday's announcement marks the second time this year that two pharmaceutical giants have agreed to merge. What is driving the consolidation, and what are the risks?
The value of new drugs through increased workforce productivity is far greater than their cost.
Professor Linda Green clarifies a common misconception about emergency room delays.
Students, faculty and alumni discussed the industry’s future at the kickoff event of the new collaborative program. Read more...
Keynote speakers Paul Keckley of Deloitte and David Holveck of Johnson & Johnson call for radical, systemic changes to the healthcare industry and the medical profession. Read more...
hw2114@columbia.edu 212-854-8955
pi17@columbia.edu 212-854-2740
rgh1@columbia.edu 212-854-2888
ll588@columbia.edu 212-854-4333
af7@columbia.edu 212-854-6084
lvg1@columbia.edu 212-854-4108
cc2663@columbia.edu 212-854-2327
frl1@columbia.edu 212-854-4408
Professor Linda Green speaks about healthcare and touches upon some of the changes proposed by the current presidential administration. Read more...
The New York Times discusses an op-ed by Dean Glenn Hubbard that argues the current administration could apply lessons from social security reform to healthcare reform debate. Read more...
Prof. Linda Green says that a focus on preventative care and disease management is the right way to bring down health care costs, rather than sending patients overseas for surgery. Read more...
An article profiles RareShare.org, a social networking site co-founded by David Isserman '10 to connect people affected by rare diseases. Read more...
MBA students report on their social enterprise summer internships Read more...
Robert Essner, former chairman and CEO of Wyeth, will work closely with the School’s healthcare program and mentor current students. Read more...
Professor Eric Johnson and co-researcher Daniel Goldstein find that the decision to become an organ donor depends on how the choice is presented. Read more...
Read more...
Professor Linda V. Green contends that the primary evidence used by the commission is an overly simplistic and potentially dangerous “ideal hospital occupancy rate” Read more...
The Health Care Industry Association (HCIA) hosted its second annual spring conference on March 31, bringing policy experts, professionals and students together to discuss critical issues in the industry. Read more...
Dean Glenn Hubbard discussed his new book, Healthy, Wealthy, and Wise: Five Steps to a Better Health Care System, on January 10 as part of Google Inc.’s author series Read more...
The key to reforming America’s health care system is increasing reliance on the free markets, rather than extending government control Read more...
Professor Linda Green and Assistant Professor Pierre Azoulay were recently honored by two internationally renowned organizations for their individual studies, which have provided practical applications in the health care and public sectors. Read more...
